Pierre van Damme

InstitutionUniversity of Antwerp
AddressBelgium
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in January 2021
    All Publications
    Bar chart showing 245 publications over 21 distinct years, with a maximum of 30 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mariën J, Ceulemans A, Bakokimi D, Lammens C, Ieven M, Heytens S, De Sutter A, Verbakel JY, Van den Bruel A, Goossens H, Van Damme P, Ariën KK, Coenen S. Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium. Fam Pract. 2022 01 19; 39(1):92-98. PMID: 34448859.
      Citations:    Fields:    
    2. Naesens R, Mertes H, Clukers J, Herzog S, Brands C, Vets P, De Laet I, Bruynseels P, De Schouwer P, van der Maas S, Bervoets K, Hens N, Van Damme P. SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital. Epidemiol Infect. 2021 08 10; 149:e172. PMID: 34372955.
      Citations:    Fields:    Translation:Humans
    3. Geysels D, Van Damme P, Verstrepen W, Bruynseels P, Janssens B, Smits P, Naesens R. SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a large Belgian hospital network. Infect Control Hosp Epidemiol. 2021 Jul 22; 1-2. PMID: 34289927.
      Citations: 2     Fields:    
    4. El Abdellati K, Coppens V, Goossens J, Theeten H, Van Damme P, Berens A, Morrens M, De Picker L. Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium. BJPsych Open. 2021 Jan 20; 7(1):e40. PMID: 33468277.
      Citations: 1     
    5. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 05 13; 384(19):1824-1835. PMID: 33440088.
      Citations: 252     Fields:    Translation:HumansCellsCTClinical Trials
    6. Molenberghs G, Buyse M, Abrams S, Hens N, Beutels P, Faes C, Verbeke G, Van Damme P, Goossens H, Neyens T, Herzog S, Theeten H, Pepermans K, Abad AA, Van Keilegom I, Speybroeck N, Legrand C, De Buyser S, Hulstaert F. Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country. Contemp Clin Trials. 2020 12; 99:106189. PMID: 33132155.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Neyens T, Faes C, Vranckx M, Pepermans K, Hens N, Van Damme P, Molenberghs G, Aerts J, Beutels P. Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium? Spat Spatiotemporal Epidemiol. 2020 11; 35:100379. PMID: 33138946.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    8. Dinleyici EC, Borrow R, Safadi MAP, van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother. 2021 Feb 01; 17(2):400-407. PMID: 32845739.
      Citations: 26     Fields:    Translation:HumansPHPublic Health